Efficacy and safety of fluoroquinolone-containing regimens in treating pulmonary Mycobacterium avium complex disease: A propensity score analysis

BACKGROUND: Although combination therapy using clarithromycin, rifampicin, and ethambutol is recommended for patients with pulmonary Mycobacterium avium complex (MAC) disease, some patients do not tolerate it because of adverse effects or underlying diseases. The efficacy and safety of fluoroquinolo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:PLoS One
Egile Nagusiak: Shuto, Hisayuki, Komiya, Kosaku, Goto, Akihiko, Kan, Takamasa, Honjo, Kokoro, Uchida, Sonoe, Takikawa, Shuichi, Yoshimatsu, Tetsuyuki, Yamasue, Mari, Hiramatsu, Kazufumi, Kadota, Jun-ichi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2020
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7347193/
https://ncbi.nlm.nih.gov/pubmed/32645105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0235797
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak